We are live on ! Find out more
UBS AM

UBS AM Portfolio holdings

AUM $481B
1-Year Est. Return 26.39%
 

UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.

This Fund
S&P 500
This Quarter Est. Return
+0.41%
1 Year Est. Return
+26.39%
3 Year Est. Return
+93.76%
5 Year Est. Return
+124.47%
10 Year Est. Return
+503.98%
AUM
$241B
AUM Growth
+$7.57B
Cap. Flow
+$8.13B
Cap. Flow %
3.37%
Top 10 Hldgs %
21.84%
Holding
2,809
New
56
Increased
1,358
Reduced
887
Closed
62

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$948M
2
SNOW icon
Snowflake
SNOW
+$542M
3
SE icon
Sea Limited
SE
+$501M
4
PG icon
Procter & Gamble
PG
+$491M
5
SNAP icon
Snap
SNAP
+$403M

Sector Composition

Rank Sector Weight
1 Technology 26.21%
2 Healthcare 13.25%
3 Financials 13.07%
4 Consumer Discretionary 12.28%
5 Communication Services 10.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRT icon
1051
Vertiv
VRT
$105B
$10.1M ﹤0.01%
417,577
+762
+0.2% +$20.3K
HE icon
1052
Hawaiian Electric Industries
HE
$2.14B
$10M ﹤0.01%
245,467
-6,733
-3% -$289K
ALLO icon
1053
Allogene Therapeutics
ALLO
$694M
$9.97M ﹤0.01%
387,941
-10,239
-3% -$243K
THC icon
1054
Tenet Healthcare
THC
$21.1B
$9.97M ﹤0.01%
149,986
-4,383
-3% -$311K
LITE icon
1055
Lumentum
LITE
$69.3B
$9.92M ﹤0.01%
118,773
-4,784
-4% -$401K
OPEN icon
1056
Opendoor
OPEN
$3.38B
$9.85M ﹤0.01%
495,834
+109,735
+28% +$1.77M
VNT icon
1057
Vontier
VNT
$4.74B
$9.84M ﹤0.01%
292,803
+5,636
+2% +$191K
EXEL icon
1058
Exelixis
EXEL
$13.4B
$9.82M ﹤0.01%
464,643
-43,751
-9% -$812K
VYX icon
1059
NCR Voyix
VYX
$1.14B
$9.77M ﹤0.01%
411,058
-3,409
-0.8% -$88.7K
CLH icon
1060
Clean Harbors
CLH
$16.3B
$9.76M ﹤0.01%
93,928
-1,909
-2% -$188K
DRH icon
1061
Diamondrock Hospitality Co
DRH
$2.56B
$9.74M ﹤0.01%
1,030,511
-129,525
-11% -$1.16M
QVCGA
1062
DELISTED
QVC Group Inc Series A
QVCGA
$9.72M ﹤0.01%
19,074
+2,195
+13% +$1.23M
ACHC icon
1063
Acadia Healthcare
ACHC
$2.94B
$9.65M ﹤0.01%
151,330
+21,744
+17% +$1.37M
OLN icon
1064
Olin
OLN
$2.12B
$9.51M ﹤0.01%
197,145
-611,331
-76% -$28.5M
RGLD icon
1065
Royal Gold
RGLD
$19.5B
$9.46M ﹤0.01%
99,111
+824
+0.8% +$92.3K
HRB icon
1066
H&R Block
HRB
$5.86B
$9.46M ﹤0.01%
378,547
-123,383
-25% -$3.07M
QDEL icon
1067
QuidelOrtho
QDEL
$838M
$9.46M ﹤0.01%
67,028
+2,165
+3% +$291K
FLO icon
1068
Flowers Foods
FLO
$1.57B
$9.45M ﹤0.01%
400,103
-6,573
-2% -$156K
SRPT icon
1069
Sarepta Therapeutics
SRPT
$1.77B
$9.44M ﹤0.01%
102,091
-9,632
-9% -$742K
CDK
1070
DELISTED
CDK Global, Inc.
CDK
$9.44M ﹤0.01%
221,799
-14,274
-6% -$643K
BJ icon
1071
BJs Wholesale Club
BJ
$12.3B
$9.38M ﹤0.01%
170,739
-882
-0.5% -$47.1K
IDA icon
1072
Idacorp
IDA
$8.2B
$9.36M ﹤0.01%
90,517
-2,215
-2% -$231K
RYN icon
1073
Rayonier
RYN
$6.55B
$9.35M ﹤0.01%
288,693
+12,825
+5% +$430K
CACC icon
1074
Credit Acceptance
CACC
$6.08B
$9.19M ﹤0.01%
15,709
+1,190
+8% +$648K
TKR icon
1075
Timken Company
TKR
$9.03B
$9.18M ﹤0.01%
140,307
-901
-0.6% -$67K

Similar funds

UBS AM's Q3 2021 Portfolio in Review

As of Q3 2021, UBS AM held 2,809 positions worth $241B, up 3.2% from $234B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

UBS AM deployed $8.13B of net new capital in Q3 2021, opening 56 new positions and adding to 1,358 existing holdings. Its largest new stake was State Street SPDR Portfolio Intermediate Term Treasury ETF: 6,053,315 shares worth $196M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Infosys, an estimated $434M trimmed.

  • UBS AM's largest Q3 2021 buy was State Street SPDR Portfolio Intermediate Term Treasury ETF: 6,053,315 shares worth $196M.
  • UBS AM added most to Microsoft in Q3 2021, an estimated $948M increase.
  • UBS AM's biggest Q3 2021 reduction was Infosys, cutting an estimated $434M.
  • UBS AM fully exited Vanguard Short-Term Treasury ETF in Q3 2021, selling an estimated $350M.
  • UBS AM's ten largest holdings make up 22% of its $241B portfolio in Q3 2021.
  • UBS AM opened 56 new positions and closed 62 in Q3 2021.
  • UBS AM's portfolio value rose 3.2% quarter-over-quarter to $241B.

Based on UBS AM's 13F filing for Q3 2021, filed 15 Nov 2021.